(NASDAQ:KZIA) shares are exploding upwards this morning on FDA award Orphan drug designation.

. KAZIA THERAPEUDICS shares are trading at $6.46 up more than 23% on the news and more than 9400 trades in pre-market.

RelatedNews

Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist